Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function (Q44407135)

2 December 2017

title

Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function (English)

1 reference

2 December 2017

Cecile Spielewoy

1

1 reference

2 December 2017

Athina Markou

series ordinal

2

1 reference

2 December 2017

language of work or name

English

0 references

publication date

26 March 2003

1 reference

2 December 2017

published in

Neuropsychopharmacology

1 reference

2 December 2017

volume

28

1 reference

2 December 2017

issue

6

1 reference

2 December 2017

page(s)

1106-1116

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300124

2 December 2017

exact match

0 references

cites work

Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Place conditioning with morphine and phencyclidine: dose dependent effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Effects of abused drugs on thresholds and breaking points of intracranial self-stimulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Phencyclidine-induced potentiation of brain stimulation reward: acute effects are not altered by repeated administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Differential effects of MK-801 on brain-derived neurotrophic factor mRNA levels in different regions of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Prediction of abuse liability of drugs using IV self-administration by rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Multifocal brain damage induced by phencyclidine is augmented by pilocarpine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Dramatic decreases in brain reward function during nicotine withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Lateralization of reward in rats: differences in reinforcing thresholds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Acute phencyclidine induces aversion, but repeated phencyclidine induces preference in the place conditioning test in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Involvement of the serotonergic neuronal system in phencyclidine-induced place aversion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Amphetamine withdrawal: a behavioral evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Drug abuse: hedonic homeostatic dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Intracranial self-stimulation thresholds: a model for the hedonic effects of drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Phencyclidine binding to striatal cocaine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

The effect of operant and electrode placement on self-stimulation train duration response functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Functional changes in neuronal systems induced by phencyclidine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Acute and chronic phencyclidine administration changes serotonin receptors in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Effects of phencyclidine on immediate early gene expression in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Molecular basis of long-term plasticity underlying addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Molecular and cellular basis of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

NMDA receptor hypofunction model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Interactions of naloxone with morphine, amphetamine and phencyclidine on fixed interval responding for intracranial self-stimulation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Simulation of psychosis by continuous delivery of phencyclidine from controlled-release polymer implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Decreased brain reward produced by ethanol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Effects of phencyclidine on [3H]catecholamine and [3H]serotonin uptake in synaptosomal preparations from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

An opponent-process theory of motivation: I. Temporal dynamics of affect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Self-stimulation and drug reward mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

Competitive and non-competitive NMDA antagonists induce similar limbic degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

MK801 induces immediate-early gene proteins and BDNF mRNA in rat cerebrocortical neurones.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

Enhanced lateral hypothalamic self-stimulation responding after chronic exposure to amphetamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

Amphetamine and the reward system: Evidence for tolerance and post-drug depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

Behavioral effects of chronic phencyclidine administration in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300124

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300124

0 references

1 reference